Rahman Pourmand, MD
Neurology · East Setauket, NYNPI 1447207386
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $107,498 of the $141,561 with a category attached, or 75.9%. AstraZeneca accounts for 95.8% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $112,667 and has fallen 99.7% since, to $356 in 2025. Among neurology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 258 payments — averaging $548.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$136K
- Catalyst Pharmaceuticals, Inc.$4K
- AbbVie$456
- Amgen$181
- Ascensia Diabetes Care US Inc.$165
- Avanir Pharmaceuticals, Inc.$157
- plus $894 from 10 others
Across 11 payments — averaging $1809.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$20K
What the payments were for
- Consulting fees$4,3453%
- Speaking & faculty fees$107,49876%
- Travel & lodging$24,61617%
- Food & beverage$5,0834%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 195 | $135,574 |
| Catalyst Pharmaceuticals, Inc. | 9 | $4,134 |
| AbbVie(2 entities) | 22 | $456 |
| Amgen(2 entities) | 9 | $181 |
| Ascensia Diabetes Care US Inc. | 1 | $165 |
| Avanir Pharmaceuticals, Inc. | 7 | $157 |
| Nalu Medical, Inc. | 1 | $142 |
| Sunovion Pharmaceuticals Inc. | 1 | $124 |
| Genentech USA, Inc. | 1 | $123 |
| Esperion Therapeutics, Inc. | 1 | $120 |
| Tanabe Pharma America, Inc. | 6 | $119 |
| Boston Scientific | 1 | $118 |
| Biohaven Pharmaceuticals, Inc. | 1 | $75 |
| Natus Medical Incorporated | 1 | $29 |
| EDW Pharma, Inc. | 1 | $25 |
| CSL Behring | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SOLIRIS$108,326
- ULTOMIRIS$1,530
- Nalu Neurostimulation System$142
- BOTOX$125
- APTIOM$124
- OCREVUS$123
- NEXLIZET$120
- NEXLETOL$120
- GENERAL PAIN MANAGEMENT$118
How this compares
$141,561 in reported general payments places this provider in the 95th percentile of 1,623 neurology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyvgartEfgartigimod Alfa-Fcab | 12 | $788,083 |
| GammakedImmune Globul G/Gly/Iga Avg 46 | 17 | $273,693 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 36 | $198,762 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 21 | $195,250 |
| Mycophenolate Mofetil | 41 | $11,681 |
| Pyridostigmine Bromide | 68 | $6,950 |
| Gabapentin | 120 | $1,426 |
| Prednisone | 49 | $436 |
| Duloxetine Hcl | 15 | $224 |
| Pantoprazole Sodium | 23 | $216 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 16 | $172 |
| Topiramate | 19 | $170 |
Paid to pharmacies, not to this prescriber.
Other neurology in East Setauket
- Patricia CoyleEast Setauket$686K
- Patricia MelvilleEast Setauket$337K
- Idan SharonBrooklyn$2.1M
- Allan PerelStaten Island$1.7M
- Nicolas SaikaliAmherst$1.5M
- David KreitzmanCommack$1.5M
- Charles ArgoffAlbany$1.2M
- Stephen KriegerNew York$1.1M
- Robert FeketeHawthorne$1M
- Jennifer McVigeAmherst$982K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.